TARDBP and sarcoma: Approximately 90 % of ALS patients are sporadic whilst 10 % are familial cases with genetic mutations in SOD1 (Cu/Zn superoxide dismutase 1), FUS (fused in sarcoma), TARDBP (also known as TDP-43) and C9ORF72, among others [1].